MVR- T7011 | Interleukin Related interleukin-related.com

Product Name :
MVR- T7011

Search keywords :
CXCL5

drugId :
null

Target Vo:
B-lymphocyte antigen CD19

Target Vo Short Name :
CD19

Moa_Name:
B-lymphocyte antigen CD19 gene transference

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Immvira Co Ltd

Active Company_Name :
Immvira Co Ltd

Active Indication_Name:
Solid tumours

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:
Preclinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Beta Actin Antibody HRP Conjugated
beta Tubulin Antibody
Thrombomodulin Antibody (YA892): Thrombomodulin Antibody (YA892) is an unconjugated, approximately 95 kDa, rabbit-derived, anti-Thrombomodulin (YA892) monoclonal antibody. Thrombomodulin Antibody (YA892) can be used for: WB expriments in mouse, rat background without labeling.

Author: Interleukin Related

Related Posts